Skip to main content
Erschienen in: Clinical and Experimental Medicine 3/2010

01.09.2010 | Original Article

The metabolic profile in patients with skin tags

verfasst von: Ramazan Sari, Ayse Akman, Erkan Alpsoy, Mustafa Kemal Balci

Erschienen in: Clinical and Experimental Medicine | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Although skin tags are associated with diabetes mellitus, insulin resistance, hypertension, obesity, atherogenic lipid profile, no data in the literature show that the presence of skin tags is associated with serum high-sensitive C-reactive protein, uric acid, free fatty acid and leptin level. The purpose of this study was to evaluate the frequency of hypertension, dyslipidemia, insulin resistance and obesity in patients with skin tags and to compare patients with skin tags and normal healthy subjects for insulin resistance, serum lipids, insulin, glucose, leptin, high-sensitive C-reactive protein, free fatty acid levels. We evaluated 113 patients with skin tags and 31 healthy subjects. The two groups were compared with respect to BMI, lipid profile, blood pressure, insulin resistance, serum lipids, insulin, glucose, leptin, high-sensitive C-reactive protein, free fatty acid and homeostatic model assessment of insulin resistance (HOMA-IR). Total 53.9 and 33.6% of patients with skin tags were overweight and obese, respectively. The frequency of hypertension 30.1%, dyslipidemia 59.3% and insulin resistance 21.2% were detected. HOMA-IR (P < 0.001) and serum glucose (P < 0.001), insulin (P = 0.002), high-sensitive C-reactive protein (P = 0.001), uric acid (P = 0.001), free fatty acid (P = 0.002), HbA1c (P < 0.001), total cholesterol (P = 0.018), LDL-cholesterol (P = 0.023), and triglyceride levels (P = 0.001) were higher in patients with skin tags than control group. Overweight and/or obesity, dyslipidemia, hypertension, insulin resistance and elevated high-sensitive C-reactive protein are seen in patients with skin tags. Skin tags may be a marker of increased risk of atherosclerosis and cardiovascular disease.
Literatur
1.
2.
Zurück zum Zitat Banik R, Lubach D (1987) Skin tags: localization and frequencies according to sex and age. Dermatologica 174(4):180–183CrossRefPubMed Banik R, Lubach D (1987) Skin tags: localization and frequencies according to sex and age. Dermatologica 174(4):180–183CrossRefPubMed
3.
Zurück zum Zitat Hidalgo LG (2002) Dermatological complications of obesity. Am J Clin Dermatol 3(7):497–506CrossRef Hidalgo LG (2002) Dermatological complications of obesity. Am J Clin Dermatol 3(7):497–506CrossRef
4.
Zurück zum Zitat Hud JA, Cohen JB, Wagner JM, Cruz PD Jr (1992) Prevalence and significance of acanthosis nigricans in an adult obese population. Arch Dermatol 128:941–944CrossRefPubMed Hud JA, Cohen JB, Wagner JM, Cruz PD Jr (1992) Prevalence and significance of acanthosis nigricans in an adult obese population. Arch Dermatol 128:941–944CrossRefPubMed
5.
6.
Zurück zum Zitat Norris PG, McFadden J, Gale E, Griffiths WA (1988) Skin tags are more closely related to fasting insulin than fasting glucose levels. Acta Derm Venereol 68(4):367–368PubMed Norris PG, McFadden J, Gale E, Griffiths WA (1988) Skin tags are more closely related to fasting insulin than fasting glucose levels. Acta Derm Venereol 68(4):367–368PubMed
7.
Zurück zum Zitat Agarwal JK, Nigam PK (1987) Acrochordon: a cutaneous sign of carbohydrate intolerance. Australas J Dermatol 28(3):132–133CrossRefPubMed Agarwal JK, Nigam PK (1987) Acrochordon: a cutaneous sign of carbohydrate intolerance. Australas J Dermatol 28(3):132–133CrossRefPubMed
8.
Zurück zum Zitat Kahana M, Grossman E, Feinstein A, Ronnen M, Cohen M, Millet MS (1987) Skin tags: a cutaneous marker for diabetes mellitus. Acta Derm Venereol 67(2):175–177PubMed Kahana M, Grossman E, Feinstein A, Ronnen M, Cohen M, Millet MS (1987) Skin tags: a cutaneous marker for diabetes mellitus. Acta Derm Venereol 67(2):175–177PubMed
9.
Zurück zum Zitat Margolis J, Margolis LS (1976) Skin tags—a frequent sign of diabetes mellitus. N Engl J Med 294(21):1184PubMed Margolis J, Margolis LS (1976) Skin tags—a frequent sign of diabetes mellitus. N Engl J Med 294(21):1184PubMed
10.
Zurück zum Zitat Hostetter AL (1995) Screening for dyslipidemia. Practice parameter. Am J Clin Pathol 103(4):380–385PubMed Hostetter AL (1995) Screening for dyslipidemia. Practice parameter. Am J Clin Pathol 103(4):380–385PubMed
11.
Zurück zum Zitat Peters AL (2000) The clinical implications of insulin resistance. Am J Manag Care 6(13):668–674 Peters AL (2000) The clinical implications of insulin resistance. Am J Manag Care 6(13):668–674
12.
Zurück zum Zitat Fernandez-Real JM, Ricart W (2003) Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 24(3):278–301CrossRefPubMed Fernandez-Real JM, Ricart W (2003) Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 24(3):278–301CrossRefPubMed
13.
Zurück zum Zitat Rifai N, Ridker PM (2001) High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 47:403–411PubMed Rifai N, Ridker PM (2001) High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 47:403–411PubMed
14.
Zurück zum Zitat Thappa DM (1995) Skin tags as markers of diabetes mellitus: an epidemiological study in India. J Dermatol 22(10):729–731PubMed Thappa DM (1995) Skin tags as markers of diabetes mellitus: an epidemiological study in India. J Dermatol 22(10):729–731PubMed
15.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28:412–419CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28:412–419CrossRefPubMed
16.
Zurück zum Zitat Dianzani C, Calvieri S, Pierangeli A, Imperi M, Bucci M, Degener AM (1998) The detection of human papillomavirus DNA in skin tags. Br J Dermatol 138(4):649–651CrossRefPubMed Dianzani C, Calvieri S, Pierangeli A, Imperi M, Bucci M, Degener AM (1998) The detection of human papillomavirus DNA in skin tags. Br J Dermatol 138(4):649–651CrossRefPubMed
17.
Zurück zum Zitat Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282:2131–2135CrossRefPubMed Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282:2131–2135CrossRefPubMed
18.
Zurück zum Zitat Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW (1999) C-reactive protein in healthy subjets: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue ? Arteriol Thromb Vasc Biol 19:972–978 Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW (1999) C-reactive protein in healthy subjets: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue ? Arteriol Thromb Vasc Biol 19:972–978
19.
Zurück zum Zitat Erdogan BS, Aktan S, Rota S, Ergin S, Evliyaoglu D (2005) Skin tags and atherosclerotic risk factors. J Dermatol 32(5):371–375PubMed Erdogan BS, Aktan S, Rota S, Ergin S, Evliyaoglu D (2005) Skin tags and atherosclerotic risk factors. J Dermatol 32(5):371–375PubMed
20.
Zurück zum Zitat Demir S, Demir Y (2002) Acrochordon and impaired carbohydrate metabolism. Acta Diabetol 39(2):57–59CrossRefPubMed Demir S, Demir Y (2002) Acrochordon and impaired carbohydrate metabolism. Acta Diabetol 39(2):57–59CrossRefPubMed
21.
Zurück zum Zitat Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G (1995) Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 95(1):158–166CrossRefPubMed Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G (1995) Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 95(1):158–166CrossRefPubMed
22.
Zurück zum Zitat Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, Bayazeed B, Baron AD (1997) Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 100(5):1230–1239CrossRefPubMed Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, Bayazeed B, Baron AD (1997) Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 100(5):1230–1239CrossRefPubMed
23.
Zurück zum Zitat Kelley DE, Mokan M, Simoneau JA, Mandarino LJ (1993) Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 92(1):91–98CrossRefPubMed Kelley DE, Mokan M, Simoneau JA, Mandarino LJ (1993) Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 92(1):91–98CrossRefPubMed
24.
Zurück zum Zitat Shankar SS, Steinberg HO (2005) FFAs: do they play a role in vascular disease in the insulin resistance syndrome? Curr Diab Rep 5(1):30–35CrossRefPubMed Shankar SS, Steinberg HO (2005) FFAs: do they play a role in vascular disease in the insulin resistance syndrome? Curr Diab Rep 5(1):30–35CrossRefPubMed
25.
Zurück zum Zitat Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Eng J Med 340:448–451CrossRef Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Eng J Med 340:448–451CrossRef
26.
Zurück zum Zitat Morrow DA, Ridker PM (2000) C-reactive protein, inflammation and coronary risk. Med Clin North Am 84:149–161CrossRefPubMed Morrow DA, Ridker PM (2000) C-reactive protein, inflammation and coronary risk. Med Clin North Am 84:149–161CrossRefPubMed
27.
Zurück zum Zitat Marques-Vidal P, Mazoyer E, Bongard V, Gourdy P, Ruidavets JB, Drouet L, Ferrieres J (2002) Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care 25(8):1371–1377CrossRefPubMed Marques-Vidal P, Mazoyer E, Bongard V, Gourdy P, Ruidavets JB, Drouet L, Ferrieres J (2002) Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care 25(8):1371–1377CrossRefPubMed
28.
Zurück zum Zitat Kawamoto R, Tomita H, Oka Y, Ohtsuka N (2006) Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis. Intern Med 45(9):605–614CrossRefPubMed Kawamoto R, Tomita H, Oka Y, Ohtsuka N (2006) Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis. Intern Med 45(9):605–614CrossRefPubMed
29.
Zurück zum Zitat Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD, Lauretani F, Bandinelli S, Senin U, Ferrucci L (2006) Uric acid and inflammatory markers. Eur Heart J 27(10):1174–1181CrossRefPubMed Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD, Lauretani F, Bandinelli S, Senin U, Ferrucci L (2006) Uric acid and inflammatory markers. Eur Heart J 27(10):1174–1181CrossRefPubMed
30.
Zurück zum Zitat Erdogan D, Gullu H, Caliskan M, Yildirim E, Bilgi M, Ulus T, Sezgin N, Muderrisoglu H (2005) Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults. Int J Clin Pract 59(11):1276–1282CrossRefPubMed Erdogan D, Gullu H, Caliskan M, Yildirim E, Bilgi M, Ulus T, Sezgin N, Muderrisoglu H (2005) Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults. Int J Clin Pract 59(11):1276–1282CrossRefPubMed
31.
Zurück zum Zitat Ren J (2004) Leptin and hyperleptinemia-from friend to foe for cardiovascular dysfunction. J Endocrinol 181(1):1–10CrossRefPubMed Ren J (2004) Leptin and hyperleptinemia-from friend to foe for cardiovascular dysfunction. J Endocrinol 181(1):1–10CrossRefPubMed
32.
Zurück zum Zitat Abdella NA, Mojiminiyi OA, Moussa MA, Zaki M, Al Mohammedi H, Al Ozairi ES, Al Jebely S (2005) Plasma leptin concentration in patients with type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance. Diabet Med 22:278–285CrossRefPubMed Abdella NA, Mojiminiyi OA, Moussa MA, Zaki M, Al Mohammedi H, Al Ozairi ES, Al Jebely S (2005) Plasma leptin concentration in patients with type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance. Diabet Med 22:278–285CrossRefPubMed
Metadaten
Titel
The metabolic profile in patients with skin tags
verfasst von
Ramazan Sari
Ayse Akman
Erkan Alpsoy
Mustafa Kemal Balci
Publikationsdatum
01.09.2010
Verlag
Springer Milan
Erschienen in
Clinical and Experimental Medicine / Ausgabe 3/2010
Print ISSN: 1591-8890
Elektronische ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-009-0086-5

Weitere Artikel der Ausgabe 3/2010

Clinical and Experimental Medicine 3/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.